Genetic and metabolic aspects of non-alcoholic fatty liver disease (NAFLD) pathogenicity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Genetic and metabolic aspects of non-alcoholic fatty liver disease (NAFLD) pathogenicity ; volume:24 ; number:1 ; day:29 ; month:8 ; year:2023 ; pages:1-14 ; date:12.2023
The Egyptian journal of medical human genetics ; 24, Heft 1 (29.8.2023), 1-14, 12.2023
- Creator
-
Samarasinghe, Saumya Madushani
Hewage, Asanka Sudeshini
Siriwardana, Rohan Chaminda
Tennekoon, Kamani Hemamala
Niriella, Madunil Anuk
De Silva, Sumadee
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43042-023-00433-x
- URN
-
urn:nbn:de:101:1-2023110712201200256639
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Samarasinghe, Saumya Madushani
- Hewage, Asanka Sudeshini
- Siriwardana, Rohan Chaminda
- Tennekoon, Kamani Hemamala
- Niriella, Madunil Anuk
- De Silva, Sumadee
- SpringerLink (Online service)
Other Objects (12)
Korrelation von Apolipoprotein C3 und non-alcoholic fatty liver disease (NAFLD)
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD)
Do artificial sweeteners increase the risk of non-alcoholic fatty liver disease (NAFLD)?
Non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Indices to represent cross-sectional non-alcoholic fatty liver disease (NAFLD) and longitudinal NAFLD development during lifestyle interventions
Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression
The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Non-alcoholic fatty liver disease (Nafld) in obese children- effect of refined carbohydrates in diet
Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)
Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy
Korrelation von Apolipoprotein C3 und non-alcoholic fatty liver disease (NAFLD)
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD)
Do artificial sweeteners increase the risk of non-alcoholic fatty liver disease (NAFLD)?
Non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Indices to represent cross-sectional non-alcoholic fatty liver disease (NAFLD) and longitudinal NAFLD development during lifestyle interventions
Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression
The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Non-alcoholic fatty liver disease (Nafld) in obese children- effect of refined carbohydrates in diet
Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)
Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy
Korrelation von Apolipoprotein C3 und non-alcoholic fatty liver disease (NAFLD)
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD)
Do artificial sweeteners increase the risk of non-alcoholic fatty liver disease (NAFLD)?
Non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Indices to represent cross-sectional non-alcoholic fatty liver disease (NAFLD) and longitudinal NAFLD development during lifestyle interventions
Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression
The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Non-alcoholic fatty liver disease (Nafld) in obese children- effect of refined carbohydrates in diet
Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)